Günlü S, Aktan A. Evaluation of the Cardiac Conduction System in Fibromyalgia Patients With Complaints of Palpitations.
Cureus 2022;
14:e28784. [PMID:
36225502 PMCID:
PMC9533093 DOI:
10.7759/cureus.28784]
[Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/04/2022] [Indexed: 11/17/2022] Open
Abstract
Objective
This study aimed to investigate the influence of fibromyalgia syndrome (FMS) on the cardiac conduction system and assess patients’ palpitation complaints using 24-h ambulatory ECG (Holter {Maynard, MA: Northeast Monitoring, Inc.}) monitoring.
Methods
Ninety patients with FMS and 70 healthy controls were included in this research. ECG was performed on all participants, and ECG parameters were calculated. Holter monitoring was conducted, and the recordings were analyzed. The results of time-domain heart rate variability (HRV) were evaluated.
Results
The patient group’s mean age was 38.3±6.3 years. There were no statistically significant differences in demographic or laboratory parameters across the groups (p>0.05). The findings of a 24-h Holter ECG recording did not vary significantly between the groups (p=0.182). In the study group, the values for the standard deviation of R-R intervals (SDNN), low frequency (LF), and low/high frequency (LF/HF), which are known as HRV indicators, were substantially different between the two groups (p<0.05).
Conclusions
The study indicated that the risk of arrhythmias did not increase even though FM patients complained of palpitations.
Collapse